US biotech major Amgen and the UK’s AstraZeneca today announced full results from the Phase III CROSSING trial of Tezspire ...

US drugmaker Collegium Pharmaceuticals announced a settlement agreement between the company and Germany’s Grunenthal.

Japan’s largest drugmaker Takeda has announced new data from VERDICT showing that treating adults with intravenous Entyvio ...

US biotech company TriGemX Bio has agreed to go public through a merger expected to generate about $246 million in gross ...

Australian biotech Starpharma saw its shares tumble 33% to A$0.50 today, after announcing that it has increased its equity ...

South Korea’s Samsung Bioepis announced a landmark 10-year agreement with its local partners in Brazil - state-level public ...

The US Food and Drug Administration has granted accelerated approval for a new use of the immunotherapy Jemperli (dostarlimab ...

US pharma major Eli Lilly (NYSE: LLY) has partnered with Chinese biotech company METiS TechBio (HKEX: 7666) to develop lipid nanoparticles (LNPs) that could deliver medicines more precisely to ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has authorized Redemplo (plozasiran) to reduce ...

German biotech Repairon, which is developing regenerative cardiac therapies, today announced the appointment of Detlef ...

Last week’s significant research news included Revolution Medicines presenting new data on its cancer drug Rasonque in KRAS mutations, and Mirum Pharmaceuticals Phase III data for its Livmarli in the ...

Founded in 2024 as a subsidiary of Sera Medicines, the company is developing new therapies for patients living with complex, heterogeneous autoimmune diseases. In August 2024, Navigator closed a $100M ...